Volume 407, Issue 10543
23 May 2026
WORLD REPORT Experts question the effectiveness of the Trump administration’s strategies to cut pharmaceutical costs in the USA. Washington Correspondent Susan Jaffe reports.
To lower prescription drug costs for Americans, the Trump Administration wielded tariff threats to gain confidential price agreements with pharmaceutical companies and promises from other countries to pay more for drugs. The lower prices are displayed on the government’s TrumpRx website but critics say that only a few brand name drugs are discounted exclusively on the website. They also say there is no guarantee that drug makers will apply any increased revenue from overseas sales to voluntarily cut prices in the USA. [Continued here.]
…